Clinical patterns of hypersensitivity to nonsteroidal anti-inflammatory drugs and their pathogenesis.
about
Systematic review of prevalence of aspirin induced asthma and its implications for clinical practicePolymorphisms of high-affinity IgE receptor and histamine-related genes in patients with ASA-induced urticaria/angioedemaA new insight into aspirin-induced asthmaA new method of oral drug provocation testing for determining safe alternatives for patients with non-steroidal anti-inflammatory drug intolerance: the triple testSafety of rofecoxib in subjects with a history of adverse cutaneous reactions to aspirin and/or non-steroidal anti-inflammatory drugsTesting for aspirin hypersensitivityThe safety of celecoxib in patients with aspirin-sensitive asthmaParacetamol and asthmaNonsteroidal anti-inflammatory drug-induced reactions and desensitizationAlternative splicing of cyclooxygenase-1 gene: altered expression in leucocytes from patients with bronchial asthma and association with aspirin-induced 15-HETE releaseEAACI/GA2LEN guideline: aspirin provocation tests for diagnosis of aspirin hypersensitivitySafety of selective cyclooxygenase-2 inhibitors and a basic non-steroidal anti-inflammatory drug (NSAID) in Japanese patients with NSAID-induced urticaria and/or angioedema: Comparison of meloxicam, etodolac and tiaramideParacetamol anaphylaxisBronchial hyperreactivity to histamine in aspirin sensitive asthmatics: relationship to aspirin threshold and effect of aspirin desensitisation.In vitro release of arachidonic acid metabolites, glutathione peroxidase, and oxygen-free radicals from platelets of asthmatic patients with and without aspirin intolerance.Aspirin-exacerbated asthma.Hypersensitivity to pyrazolones.Hypersensitivity to nonsteroidal anti-inflammatory drugs (NSAIDs) - classification, diagnosis and management: review of the EAACI/ENDA(#) and GA2LEN/HANNA*.Prostaglandins, thromboxanes and leukotrienes in clinical medicineAsthma relieved by aspirin and by other cyclo-oxygenase inhibitorsThe aspirin diseaseKetorolac-induced bronchospasm in an aspirin-intolerant patientInhibition of idiosyncratic reactions to aspirin in asthmatic patients by clemastine.The time delay between drug intake and bronchospasm for nonsteroidal antiinflammatory drugs sensitive patients.Tolerance to alternative cyclooxygenase-2 inhibitors in nonsteroidal anti-inflammatory drug hypersensitive patients.Role of aspirin and other nonsteroidal anti-inflammatory drugs in aspirin-exacerbated respiratory disease.Association of Acetaminophen and Ibuprofen Use With Wheezing in Children With Acute Febrile Illness.The biology, pathophysiology and control of eicosanoids in inflammation.Vasomotor rhinitis: neglected cause of nasal congestion.Aspirin, paracetamol and non-steroidal anti-inflammatory drugs. A comparative review of side effects.Nonsteroidal anti-inflammatory drugs. Their use in dermatology.Effect of ETYA and BW 755c on arachidonate-induced contractions in the guinea-pig isolated trachea.Practical approach to the treatment of NSAID hypersensitivity.Analgesic-antipyretic choices for children with asthma: a review of safety and risk of common preparations.Aspirin intolerance and recurrent urticaria in normal adults and children. Epidemiology and review.A moderate and unspecific release of cysteinyl leukotrienes by aspirin from peripheral blood leucocytes precludes its value for aspirin sensitivity testing in asthma.Mechanism of aspirin-induced asthma.Differential effect of acetylsalicylic acid and dipyrone on prostaglandin production in human fibroblast cultures.Indomethacin enhances the effect of histamine on airways resistance in the anaesthetized guinea-pig.Tartrazine: a potentially hazardous dye in Canadian drugs
P2860
Q24600284-DB2103FC-8EDF-4FB9-918D-8A6BC6A7EA61Q28177148-4653D0D3-1294-416B-BFA5-9F9CBC406CACQ28192535-B9DEBA48-8D8F-428D-89DA-02CB16A0C1A3Q28192672-7064F216-22A9-403B-91AF-EF2AD1EC0563Q28192717-E83E5C15-7BB4-45FE-8708-A602F5F2C164Q28193348-3F80EDFF-75CC-4842-B910-7A39F28BAA09Q28193684-433652B2-C012-4852-A0C4-098C212CB797Q28194589-4129497B-1917-4F7E-82CF-A840E746B506Q28209835-3A0ACD2F-9761-4FD7-9E2A-3A7C716B3D7AQ28210944-66E3BD7A-616D-42E5-AEA9-DDB9563EA9D0Q28211293-D76ED160-B0F1-47F0-87E3-34105F838E2BQ28218881-88E9FAD7-82B6-431E-AB52-02BAC4D51146Q28317133-D290DB58-3C55-4E38-8ED4-60A290F610D5Q33603803-3B1A3709-1ED6-4072-B04C-841AEA4577A8Q33604882-FC50DC91-862B-430B-B3D4-D28B482499A4Q33846722-C7A5F462-CF43-404D-9896-ABEC0AAA3009Q34036262-79C8AABB-E4A0-4D2B-AA81-AC083DCF1D73Q34188879-A8047DF0-0985-4163-BD82-257C99D5654EQ34192889-88DD34BA-3ADC-4BA1-82C4-CC30189F30A7Q34717104-52132C3F-E55C-4604-AFD9-5507FBAD4BC0Q35577349-B375CB40-C3DD-4214-9F4E-681623FFFA36Q36289809-DE6B4807-9CCA-44E5-B9FB-8AD83A93ABF5Q36458603-2ED20E39-DFFB-42AD-8259-6E7A2D89EB5AQ36834723-1AD9AC53-D812-4ABD-9C65-13D2AD1D42FAQ36992581-6E6BEF9D-7DD9-4EB8-9291-CE906C36AA31Q37754746-87BD017D-6A77-4453-9003-7CAAA3EF0B20Q39236288-594C849B-854F-4E0A-A7A7-C463240C3EDAQ39493756-78077CD4-100A-4D8F-A36A-61667235FC93Q39573693-995EDE4B-3F53-484D-A540-DD8B40808441Q39675366-7CF4920F-7EDE-431B-83AA-8A79FE7BADC5Q39764796-E7C7262E-DA73-49C1-903A-BB3B9963A5C4Q39933209-47229C48-831E-4D92-907B-6B25C9EFB30AQ40039561-30DA0613-1292-4BC0-91AC-6443EBE24228Q40214906-0B52FC07-A3F9-47AB-AF88-2EE612676C63Q40361676-0B98A8B8-229F-4FF3-AD04-2FA83C861E90Q40836591-0E295C42-1C67-433B-A517-38FCFEF3C2E4Q41534071-C5A82324-37B9-48A6-BC14-EDB96436A8A6Q41761431-D6409536-0B9A-48C1-894F-6284DB997F16Q41808702-2E303E53-09DE-45C9-9C51-9BF5739E14E9Q41859666-7331494A-19ED-4BA0-9108-A84F6A43E5EE
P2860
Clinical patterns of hypersensitivity to nonsteroidal anti-inflammatory drugs and their pathogenesis.
description
1977 nî lūn-bûn
@nan
1977年の論文
@ja
1977年学术文章
@wuu
1977年学术文章
@zh-cn
1977年学术文章
@zh-hans
1977年学术文章
@zh-my
1977年学术文章
@zh-sg
1977年學術文章
@yue
1977年學術文章
@zh
1977年學術文章
@zh-hant
name
Clinical patterns of hypersens ...... drugs and their pathogenesis.
@en
type
label
Clinical patterns of hypersens ...... drugs and their pathogenesis.
@en
prefLabel
Clinical patterns of hypersens ...... drugs and their pathogenesis.
@en
P1476
Clinical patterns of hypersens ...... drugs and their pathogenesis.
@en
P2093
Czerniawska-Mysik G
Gryglewski RJ
P304
P356
10.1016/0091-6749(77)90106-3
P407
P577
1977-11-01T00:00:00Z